Drugs & Diseases

Recent Drug Updates

  • onabotulinumtoxinA (Botox) First neurotoxin approved for neurogenic detrusor overactivity in children and adolescents
  • cemiplimab (Libtayo) FDA approves PD-1 inhibitor for basal cell carcinoma
  • etesevimab FDA grants monoclonal antibody emergency use for COVID-19 infection in patients at high risk of hospitalization

Slideshow Collections